This content is restricted to site members. If you are an existing user, please log in. New users may register too.
CAMBRIDGE, England–(BUSINESS WIRE)–PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Steven S. Martin to its board. Mr Martin is managing partner of Paxton Advisors, LLC a business advisory and consulting firm based in Omaha, Nebraska. Previously, Mr Martin was President and Chief Executive Officer for Blue Cross and Blue Shield of Nebraska (BCBSNE), leading the company’s executive management team for over 16 years and serving as a member of the board of directors from March 2002 until March 2018. BCBSNE, an independent licensee of the Blue Cross